Overlaid text reading Standardizing Compliance Across Private Equity Healthcare Portfolios beside a glass office building

Standardizing Compliance Across Private Equity Healthcare Portfolios: Case Study Insights

Standardizing Compliance Across Private Equity Healthcare Portfolios: Case Study Insights

Buying a healthcare practice does not mean its compliance program is ready to join the rest of the portfolio.

One location may have current policies and regular training. Another may rely on an outdated handbook. Employees at a third practice might not know where to report a concern.

Getting these organizations on the same page takes more than sending out a shared policy manual. Leaders need a way to identify problems, assign responsibility, and make sure issues get resolved. They also need to account for differences in services, state laws, and day-to-day operations.

Government guidance and enforcement actions offer some useful lessons on where to start.

A Shared Policy Manual Is Only the Beginning

The HHS Office of Inspector General (OIG) outlines seven elements of an effective compliance program:

  • Written policies and procedures.
  • Compliance leadership and oversight.
  • Training and education.
  • Communication and reporting channels.
  • Consistent enforcement of standards.
  • Risk assessment, auditing, and monitoring.
  • Responses to problems and corrective action.

These elements provide a starting point for organizations across a healthcare portfolio. OIG's General Compliance Program Guidance is voluntary, though. It does not require every organization to operate an identical program.

The practical goal is to establish common expectations while leaving room for the requirements and risks of each business.

For example, every organization should know how to report a compliance concern. The person responsible for investigating it may differ by location or type of issue.

Case Study: Patient Care America

A federal settlement involving Patient Care America shows why compliance oversight needs to extend beyond the practice or billing office.

In 2019, the Department of Justice announced that the compounding pharmacy, two executives, and private equity firm Riordan, Lewis & Haden agreed to pay approximately $21.36 million to resolve False Claims Act allegations involving prescriptions reimbursed by TRICARE.

The government alleged that the pharmacy paid outside marketers to generate prescriptions for compounded creams and vitamins regardless of patient need. It also alleged that the private equity firm knew of and agreed to the marketing arrangement and financed the kickback payments.

The settlement resolved allegations. There was no determination of liability.

What portfolio leaders can take from this case

Marketing arrangements and funding decisions deserve compliance attention, just as billing and documentation do.

Practical steps include:

  • Reviewing marketing and referral-related agreements before they are signed.
  • Looking closely at compensation tied to healthcare business.
  • Investigating unusual growth in high-reimbursement services.
  • Giving compliance staff a way to raise concerns about business decisions.
  • Documenting how leadership addressed those concerns.

These steps reflect OIG's broader recommendation to examine financial incentives and "follow the money" when evaluating potential compliance risks.

Common Ownership Does Not Remove Referral Risks

It can be easy to assume that arrangements between businesses in the same portfolio are less risky than arrangements with outside companies.

That assumption can cause problems.

OIG explains that common ownership does not automatically protect payments between organizations from scrutiny under the federal Anti-Kickback Statute. The facts and intent behind an arrangement still matter.

A portfolio might include physician practices and other healthcare businesses that serve the same patients. Before introducing referral processes, shared marketing arrangements, or payments between those businesses, leaders should have the arrangements reviewed.

Internal relationships should not bypass the review process simply because the organizations share an investor.

What Should Be Consistent Across the Portfolio?

Not every procedure needs to be identical. Some basic processes, however, are easier to oversee when organizations use a common approach.

Area

A practical approach

Leadership

Identify who handles compliance locally and which issues must go to portfolio leadership or the governing body.

Policies

Use approved core policies with a process for local changes and updates.

Training

Set common expectations, then add education for specific jobs and services.

Reporting

Give employees clear reporting options and explain the organization's nonretaliation expectations.

Auditing

Use a consistent process to document findings and assign corrective actions.

Follow-up

Check whether corrective actions worked, not just whether someone marked them complete.

These are suggested ways to apply OIG's compliance framework. They are not a separate government requirement for managing a healthcare portfolio.

Where Local Differences Still Matter

A policy that works for one organization may not address another organization's risks.

A physician practice and a compounding pharmacy, for example, may need different auditing priorities. Their services, billing practices, and business relationships are not the same.

State requirements also need attention. HIPAA generally does not override contrary state health information privacy laws that provide more stringent protections. A shared privacy policy may need state-specific provisions.

One workable approach is to use:

  • A core policy that sets the common standard.
  • Local procedures that explain how employees carry it out.
  • State-specific additions where needed.
  • A designated person responsible for updates.

This keeps organizations from starting from scratch without forcing every location to use instructions that do not fit its work.

Bringing a Newly Acquired Practice Into the Program

A new acquisition is a good time to look closely at existing practices. It is not a reason to assume that everything is in order.

The following steps offer a practical way to organize that review.

Start with what is already there

Gather policies, training records, prior audits, complaints, and open corrective-action plans.

Look for unresolved issues as well as missing documents. An organization may have a policy on paper while employees follow a different process.

Make responsibility clear

Employees need to know who handles questions and concerns after the acquisition. Local managers also need to understand which issues they can address and which require escalation.

Do not leave those decisions to guesswork.

Review the higher-risk activities first

The priorities will depend on the organization. Areas to consider include billing, documentation, marketing, referral relationships, and patient information safeguards.

Use the organization's actual risks to guide the work rather than applying the same checklist in the same order everywhere.

Check whether changes are working

Sending a policy and collecting acknowledgments does not show whether the process works.

Ask employees how they would handle a concern. Review a sample of work. Follow up on earlier findings. These checks can reveal gaps that training records alone will not show.

Look Beyond Completion Rates

Training completion and policy acknowledgments have a place in compliance reporting. They should not be the only things leadership sees.

A more useful report may also show:

  • Findings that keep coming back.
  • Corrective actions that are overdue.
  • Problems reported at more than one organization.
  • Issues that need a leadership decision.
  • Follow-up results showing whether a problem was resolved.

This gives leaders a better chance of spotting a wider issue before each organization has to discover it separately.

The value of a shared compliance program is not the number of policies it produces. It is whether people recognize concerns, report them, and take appropriate action.

Frequently Asked Questions

Does OIG require every organization in a private equity healthcare portfolio to use the same compliance program?

No. OIG's General Compliance Program Guidance is voluntary and allows organizations to tailor their programs to their circumstances. Separate laws, regulations, contracts, or settlement obligations may impose specific requirements.

Can organizations under common ownership refer patients to each other?

Common ownership does not automatically make a referral or payment arrangement permissible. OIG explains that payments between commonly owned entities can raise Anti-Kickback Statute concerns. Arrangements need review based on the facts and applicable requirements.

Can one policy manual cover the entire portfolio?

A shared manual can establish common expectations, but it may need local procedures and state-specific additions. It should reflect the services and requirements of the organizations using it.

Can a private equity investor be included in a healthcare enforcement action?

Yes. The Patient Care America settlement included a private equity firm based on allegations about its involvement in the challenged arrangement. The settlement did not establish liability, but it illustrates why investor-level decisions also need compliance review.

Where should portfolio leaders start?

Start by identifying who is responsible for compliance and reviewing the risks at each organization. Compare existing practices with OIG's seven compliance program elements, prioritize significant gaps, and follow corrective actions through to completion.

Sources